# Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer

> **NCT00892801** · PHASE1 · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 5 (actual)

## Conditions studied

- Lung Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** RAD001
- **RADIATION:** whole-brain radiation therapy

## Key facts

- **NCT ID:** NCT00892801
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Terminated due to low accrual. Study was closed to accrual prematurely and did not continue on to Phase II.
- **Last updated:** 2012-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00892801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00892801, "Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00892801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*